Aditya Yadav

\"As a downstream professional, I specialize in purifying and processing therapeutic proteins, ensuring high-quality, safe, and effective biopharmaceuticals through expertise in chromatography, filtration, and more.\"

Role: Research Trainee at Biogenomics
Location: Mumbai, MH, IN
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

Experience

Research Trainee
Biogenomics
Sep 2024 — Present · Thane, IN
Designing, conducting, and analyzing experiments to develop and optimize processes for the batch production of recombinant proteins, including Insulin Aspart, Recombinant Trypsin, and Recombinant CPB, in compliance with Good Manufacturing Practices (GMP) and Good Documentation Practices (GDP).

Education

Twins
High School Diploma
2016 — 2017
D Y PATIL DEEMED TO BE UNIVERSITY, SCHOOL OF MANAGEMENT
MSC. PHARMA. BIOTECHNOLOGY
2022 — 2024
BN
Bachelor of Science
2019 — 2022
BN bandodkar college of science
Bachelor of Science - BS
2019 — 2022
NKTT
12TH STD
2018 — 2019
Dy patil deemed to be University School of Biotechnology and Bioinformatics CBD Belapur Navi Mumbai
Msc biotechnology
2022

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@biogenomics.co.in
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Biogenomics

Pharmaceutical Manufacturing · 292 employees · Thane, Maharashtra, India

Biogenomics is a science-driven, vertically integrated pharmaceutical company specializing in treatments for diabetes and oncology. Backed by Oman Investment Authority and guided by a team of distinguished scientists, business leaders, and experts in molecular biology, microbiology, and protein engineering, Biogenomics has in a short span of time has developed a wide portfolio of biosimilars and biotech products. As an industry pioneer, Biogenomics became the first company in India to successfully launch a biosimilar of Insulin Aspart. With a robust pipeline, the company has several additional products awaiting approval. Committed to enhancing patient outcomes globally, Biogenomics has an active clinical development program focused on advancing chemical entities and biologics for the treatment of diabetes, cancer, and other critical therapeutic areas. As a young, fast-growing biopharmaceutical firm, Biogenomics is on a path to delivering excellence in healthcare. Our mission is to enrich lives by providing high-quality, affordable drugs, ensuring patient access to expensive specialty pharmaceuticals and biologic treatments. With two new additional manufacturing facilities coming up in India and Oman, Biogenomics is poised for significant global expansion. Beginning filings in 2025, the company plans to extend its reach into North America, Europe, and other key markets, further solidifying its international presence.

biogenomics.co.in

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Research Trainee

Education

Twins

D Y PATIL DEEMED TO BE UNIVERSITY, SCHOOL OF MANAGEMENT

BN

BN bandodkar college of science

NKTT

Dy patil deemed to be University School of Biotechnology and Bioinformatics CBD Belapur Navi Mumbai

Find verified contacts for anyone on LinkedIn